GC Rieber VivoMega expands omega-3 portfolio with launch of vegan DHA and EPA algal oil

GC Rieber VivoMega has introduced a new high-potency vegan omega-3 ingredient, Algae 1045 TG, designed to support the nutraceutical sector’s shift toward sustainable, plant-based formulations, a February 17 press release from the company explains.¹ The launch expands the company’s algae-derived portfolio with a triglyceride-form docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) concentrate positioned to support both performance and cost efficiency. The company will be present at Natural Products Expo West 2026 in Anaheim, California to discuss more about its omega-3 portfolio and its emphasis on sustainability initiatives.

Ingredient specifications and production

The new Algae 1045 TG ingredient delivers a concentrated blend of the omega-3 fatty acids DHA and EPA while offering clean-label solutions for brands and sensory experiences for consumers, the press release explains. By offering DHA and EPA in triglyceride form, the formulation is intended to preserve bioavailability and purity, and to support multiple applications.

Production relies on GC Rieber VivoMega’s proprietary SuperLight processing technology, developed specifically for algae oils. The non-invasive approach is engineered to enhance oxidation protection, safeguard molecular integrity, and optimize overall resource utilization. According to the company, these processing efficiencies also support minimal-to-zero waste outcomes.

Commercial positioning is another focal point of the launch. The company describes the ingredient as a cost-effective option that maintains premium quality benchmarks.

Production and supply chain insights

In a recent interview with Nutritional Outlook, Kristi Ekrann Aarak, technical business development manager at GC Rieber VivoMega, and Merethe Thomassen, communications and marketing manager at GC Rieber VivoMega offered more perspective on technical and market aspects of the company.² “At GC Rieber VivoMega, quality and compliance are central to everything we do,” explained Ekrann Aarak. “Our production follows strict standards for traceability, documentation, and regulatory compliance, all the way from raw material sourcing through final product delivery. We operate under GOED (Global Organization for EPA and DHA Omega-3), EFSA (European Food Safety Authority), and global quality frameworks, supported by rigorous internal controls, validated analytical methods, and continuous audits. Every batch is fully documented and traceable, ensuring consistent quality, safety, and transparency for our customers.”

Sustainability across the supply chain is another factor considered by GC Rieber VivoMega. “When ensuring a traceable and sustainable supply chain, key challenges include raw material transparency, supply stability, and credible certification,” explains Thomassen. “GC Rieber VivoMega addresses these through close supplier collaboration, third-party verification, and continuous improvement of traceability systems. We see sustainability as a shared responsibility across the value chain, ensuring that every product we deliver meets high environmental, ethical, and quality standards our customers can trust.”

Shifts in omega-3 market demand

Ståle Søfting, sales and marketing director at GC Rieber VivoMega, emphasized the current shifts in market demand for omega-3 solutions and how the new launch aims to reinforce the company’s broader commitment to responsibly sourced, high-quality omega-3 concentrates. “Consumer demand for sustainable and traceable omega-3 solutions continues to rise, and our new Algae 1060 TG Premium reflects our commitment to combining sustainability, innovation, and commercial flexibility,” he stated. “Brands today are looking for plant-based omega-3 solutions that deliver both performance and price competitiveness. With this launch, we are providing a high-concentration, certified vegan option that supports formulation efficiency while maintaining the quality and sustainability standards our customers expect.”

Thomassen also highlights how the company navigates opportunities in the entire omega-3 market. “Market-wise, algae oil meets the growing vegan and plant-based demand (flexitarian), while fish oil remains the most cost-effective and 'known' source,” she explains. “VivoMega’s strength lies in mastering both fish and algae and offering customers flexibility and quality, tailored to their needs.”

This article was created with assistance from AI. The content has been reviewed and edited by Erin McEvoy, Associate Editor. For more information on the extent and nature of AI usage, please contact us.

References

1. GC Rieber VivoMega. GC Rieber VivoMega Launches New Vegan DHA + EPA Algal Oil at NPEW, Expanding its Vegan Omega-3 Portfolio. February 17, 2026. (Accessed 2026-02-18)
2. McEvoy, E. How GC Rieber VivoMega is adapting fish and algal omega-3 production to a changing market. January 27, 2026. https://www.nutritionaloutlook.com/view/how-gc-rieber-vivomega-is-adapting-fish-and-algal-omega-3-production-to-a-changing-market (Accessed 2026-02-18).